Annual Working Capital
$3.78 M
+$9.47 M+166.29%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual working capital is $3.78 million, with the most recent change of +$9.47 million (+166.29%) on December 31, 2023.
- During the last 3 years, AVTX annual working capital has fallen by -$7.00 million (-64.96%).
- AVTX annual working capital is now -91.00% below its all-time high of $41.96 million, reached on December 31, 2021.
Performance
AVTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$25.47 M
+$25.98 M+5164.41%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly working capital is $25.47 million, with the most recent change of +$25.98 million (+5164.41%) on September 30, 2024.
- Over the past year, AVTX quarterly working capital has increased by +$25.98 million (+5164.41%).
- AVTX quarterly working capital is now -56.06% below its all-time high of $57.97 million, reached on September 30, 2021.
Performance
AVTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AVTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +166.3% | +5164.4% |
| 3 y3 years | -65.0% | +547.1% |
| 5 y5 years | +188.2% | +645.1% |
AVTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.0% | +166.3% | -39.3% | +124.4% |
| 5 y | 5-year | -91.0% | +166.3% | -56.1% | +124.4% |
| alltime | all time | -91.0% | +166.3% | -56.1% | +124.4% |
Avalo Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $25.47 M(-5164.4%) |
| Jun 2024 | - | -$503.00 K(-99.5%) |
| Mar 2024 | - | -$104.49 M(-2866.4%) |
| Dec 2023 | $3.78 M(-166.3%) | $3.78 M(-43.2%) |
| Sep 2023 | - | $6.65 M(-144.6%) |
| Jun 2023 | - | -$14.94 M(+274.1%) |
| Mar 2023 | - | -$3.99 M(-29.9%) |
| Dec 2022 | -$5.70 M(-113.6%) | -$5.70 M(-538.0%) |
| Sep 2022 | - | $1.30 M(-447.9%) |
| Jun 2022 | - | -$374.00 K(-101.5%) |
| Mar 2022 | - | $25.77 M(-38.6%) |
| Dec 2021 | $41.96 M(+289.2%) | $41.96 M(-27.6%) |
| Sep 2021 | - | $57.97 M(+125.6%) |
| Jun 2021 | - | $25.69 M(+30.2%) |
| Mar 2021 | - | $19.74 M(+83.1%) |
| Dec 2020 | $10.78 M(+93.8%) | $10.78 M(-55.9%) |
| Sep 2020 | - | $24.46 M(-31.4%) |
| Jun 2020 | - | $35.65 M(+251.0%) |
| Mar 2020 | - | $10.16 M(+82.5%) |
| Dec 2019 | $5.56 M | $5.56 M(-219.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -$4.67 M(-4.0%) |
| Jun 2019 | - | -$4.87 M(+249.9%) |
| Mar 2019 | - | -$1.39 M(-67.5%) |
| Dec 2018 | -$4.28 M(+932.2%) | -$4.28 M(-33.5%) |
| Sep 2018 | - | -$6.44 M(-10.7%) |
| Jun 2018 | - | -$7.21 M(+416.3%) |
| Mar 2018 | - | -$1.40 M(+236.3%) |
| Dec 2017 | -$415.10 K(-130.7%) | -$415.10 K(-101.8%) |
| Sep 2017 | - | $23.27 M(+442.6%) |
| Jun 2017 | - | $4.29 M(+493.9%) |
| Mar 2017 | - | $722.20 K(-46.5%) |
| Dec 2016 | $1.35 M(-91.4%) | $1.35 M(-32.3%) |
| Sep 2016 | - | $2.00 M(-69.5%) |
| Jun 2016 | - | $6.55 M(-38.9%) |
| Mar 2016 | - | $10.72 M(-32.0%) |
| Dec 2015 | $15.77 M(+120.1%) | $15.77 M(-586.6%) |
| Sep 2015 | - | -$3.24 M(-756.2%) |
| Jun 2015 | - | $493.90 K(-84.8%) |
| Mar 2015 | - | $3.25 M(-54.6%) |
| Dec 2014 | $7.17 M(+569.7%) | $7.17 M |
| Dec 2013 | $1.07 M | - |
FAQ
- What is Avalo Therapeutics annual working capital?
- What is the all time high annual working capital for Avalo Therapeutics?
- What is Avalo Therapeutics annual working capital year-on-year change?
- What is Avalo Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly working capital year-on-year change?
What is Avalo Therapeutics annual working capital?
The current annual working capital of AVTX is $3.78 M
What is the all time high annual working capital for Avalo Therapeutics?
Avalo Therapeutics all-time high annual working capital is $41.96 M
What is Avalo Therapeutics annual working capital year-on-year change?
Over the past year, AVTX annual working capital has changed by +$9.47 M (+166.29%)
What is Avalo Therapeutics quarterly working capital?
The current quarterly working capital of AVTX is $25.47 M
What is the all time high quarterly working capital for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly working capital is $57.97 M
What is Avalo Therapeutics quarterly working capital year-on-year change?
Over the past year, AVTX quarterly working capital has changed by +$25.98 M (+5164.41%)